糖尿病诱导心脏祖细胞miRNA失调影响生存增殖与自我更新
研究比较2型糖尿病db/db小鼠与非糖尿病小鼠及人右心耳组织来源心脏祖细胞(CPC)的miRNA表达谱,发现糖尿病CPC中16个miRNA显著失调,其中miR-30c-5p下调、miR-329-3p等上调;过表达miR-30c-5p可抑制VDAC1减少凋亡并保护线粒体膜电位。
要点
- 糖尿病CPC中miR-30c-5p下调,miR-329-3p、miR-376c-3p、miR-495-3p上调。
- miR-30c-5p直接靶向促凋亡蛋白VDAC1。
- 过表达miR-30c-5p可减少糖尿病CPC凋亡并保护线粒体膜电位。
核心结论
- 糖尿病诱导CPC中与生存、增殖和分化相关的miRNA显著失调。
- 治疗性过表达促生存miR-30c-5p通过抑制新靶点VDAC1减少糖尿病诱导的CPC死亡和MMP丢失。
研究设计与样本
- 从2型糖尿病db/db小鼠、非糖尿病小鼠及人右心耳组织分离心脏祖细胞(CPC)。
- 对小鼠CPC总RNA行Nanostring miRNA谱分析,共分析599个miRNA。
- 采用生物信息学预测功能,MS分析确定靶点,western blot验证。
- 在小鼠和人糖尿病CPC中体外过表达miR-30c-5p,并在体内评估凋亡、心脏功能和线粒体膜电位(MMP)。
主要发现
- 599个miRNA中,糖尿病CPC有16个miRNA显著失调。
- 经生物信息学和qPCR验证,4个miRNA(miR-30c-5p、miR-329-3p、miR-376c-3p、miR-495-3p)在细胞增殖和生存中起重要作用。
- 糖尿病显著下调miR-30c-5p,上调miR-329-3p、miR-376c-3p和miR-495-3p。
- MS分析显示VDAC1是miR-30c-5p直接靶点,CDK6是miR-329-3p、miR-376c-3p和miR-495-3p直接靶点。
- Western blot显示糖尿病CPC中VDAC1表达显著增加,CDK6表达下调。
临床怎么用
- 提示miR-30c-5p-VDAC1轴可能是改善糖尿病心脏祖细胞功能的潜在治疗靶点。
- 糖尿病状态下心脏祖细胞miRNA失调或参与干细胞功能减退,需进一步临床转化验证。
局限性
- 研究主要基于小鼠模型和有限人右心耳组织,样本量未报告。
- miRNA失调与心功能的因果关系及临床相关性尚需更多在体研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Diabetes mellitus causes a progressive loss of functional efficacy in stem cells, including cardiac progenitor cells (CPCs). The underlying molecular mechanism is still not known. MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate genes at the post-transcriptional level. We aimed to determine if diabetes mellitus induces dysregulation of miRNAs in CPCs and to test if in vitro therapeutic modulation of miRNAs would improve the functions of diabetic CPCs. METHODS: CPCs were isolated from a mouse model of type 2 diabetes (db/db), non-diabetic mice and human right atrial appendage heart tissue. Total RNA isolated from mouse CPCs was miRNA profiled using Nanostring analysis. Bioinformatic analysis was employed to predict the functional effects of altered miRNAs. MS analysis was applied to determine the targets, which were confirmed by western blot analysis. Finally, to assess the beneficial effects of therapeutic modulation of miRNAs in vitro and in vivo, prosurvival miR-30c-5p was overexpressed in mouse and human diabetic CPCs, and the functional consequences were determined by measuring the level of apoptotic cell death, cardiac function and mitochondrial membrane potential (MMP). RESULTS: Among 599 miRNAs analysed in mouse CPCs via Nanostring analysis, 16 miRNAs showed significant dysregulation in the diabetic CPCs. Using bioinformatics tools and quantitative real-time PCR (qPCR) validation, four altered miRNAs (miR-30c-5p, miR-329-3p, miR-376c-3p and miR-495-3p) were identified to play an important role in cell proliferation and survival. Diabetes mellitus significantly downregulated miR-30c-5p, while it upregulated miR-329-3p, miR-376c-3p and miR-495-3p. MS analysis revealed proapoptotic voltage-dependent anion-selective channel 1 (VDAC1) as a direct target for miR-30c-5p, and cell cycle regulator, cyclin-dependent protein kinase 6 (CDK6), as the direct target for miR-329-3p, miR-376c-3p and miR-495-3p. Western blot analyses showed a marked increase in VDAC1 expression, while CDK6 expression was downregulated in diabetic CPCs. Finally, in vitro and in vivo overexpression of miR-30c-5p markedly reduced the apoptotic cell death and preserved MMP in diabetic CPCs via inhibition of VDAC1. CONCLUSIONS/INTERPRETATION: Our results demonstrate that diabetes mellitus induces a marked dysregulation of miRNAs associated with stem cell survival, proliferation and differentiation, and that therapeutic overexpression of prosurvival miR-30c-5p reduced diabetes-induced cell death and loss of MMP in CPCs via the newly identified target for miR-30c-5p, VDAC1.
引用
- Purvis N, Kumari S, Chandrasekera D, et al. Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells. Diabetologia. 2021. PMID: 33655378. doi:10.1007/s00125-021-05405-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。